News
AZ gets first okay for new hypertension drug baxdrostat
AstraZeneca is the first company to get FDA approval for an aldosterone synthase inhibitor for hypertension, ahead of rival Mineralys.
News
FDA hands BeOne, Taiho approvals for blood cancers
BeOne gets the nod for BCL2 inhibitor Beqalzi in mantle cell lymphoma, while Taiho's Inqovi has acute myeloid leukaemia added to its label.
Sales & Marketing
Sponsored
Solution Spotlight: Medscape One
Medscape One (M1) is a sophisticated, AI-powered decision engine designed to redefine HCP engagement.
News
GSK enlists local aid for Chinese rollout of hep B drug
GSK has partnered Sino Biopharm to make the most of the Chinese launch of hepatitis B drug bepirovirsen, currently under NMPA review.
News
Partner's Bizengri is first drug for rare, aggressive cancer
Partner's Bizengri has been approved for a rare form of bile duct cancer, two days after being awarded a national priority review voucher.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
